Vyne Therapeutics 发布了最新公告。该公告涉及现金分红、反向拆股,以及其与 Yarrow Bioscience 拟议合并的预期交割时间。这一系列关键事项的最新进展,现已向市场公开。
Vyne Therapeutics 发布了最新公告。该公告涉及现金分红、反向拆股,以及其与 Yarrow Bioscience 拟议合并的预期交割时间。这一系列关键事项的最新进展,现已向市场公开。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.